Sartorius upscales gene therapy prowess with $2.6bn Polyplus acquisition
Pharmaceutical Technology
APRIL 3, 2023
The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. In the dynamically growing market for cell and gene therapies, viral vectors are needed to deliver the genes of interest into cells.
Let's personalize your content